Update regarding the ongoing application process for national approval of
biocidal products (disinfection products) in Norway (with reference to the stock
exchange announcement from SoftOx Solutions AS (SoftOx) on March 29th and July
2. 2021).

The Norwegian Environment Agency has rejected that SoftOx 'hand disinfection can
be covered by a transitional scheme during the period in which the application
for product approval is processed. The Norwegian Environment Agency's
interpretation of the regulations is disputed by SoftOx.

 - The company does not understand the directorate's interpretation of the text
in the hearing proposal. The situation has been assessed together with leading
lawyers. Our opinion is that the NEA here has made a mistake. That SoftOx as a
small company should now bear the risk of mistakes made by the Norwegian
Environment Agency is perceived as grossly unfair, says CEO Geir Almås of SoftOx
Solutions.

SoftOx has two processes towards regulatory authorities associated with its
disinfection products: application for approval based on active chlorine
released from hypochloric acid and an application for approval based on active
chlorine released from sodium hypochlorite. The products are identical, except
for a regulatory term for active substance. The fact that the company has two
ongoing application processes is  because the regulations are complex and that
they are interpreted differently from country to country.

SoftOx's application for approval of the product family in disinfection based on
active chlorine released from hypochlorous acid has been submitted in accordance
with requirements specified in the Norwegian Environment Agency's hearing
memorandum from March 2021 to new regulations (2021/2157). SoftOx bases its
opinion on the fact that there is a transitional arrangement for all
disinfection products when the application for approval was submitted within the
deadline specified in the hearing memorandum. However, the Norwegian Environment
Agency has by letter, and as part of an ongoing dialogue, announced that the
that there should be no transitional scheme for products based on active
chlorine from hypochlorous acid Product type 1 (hand disinfection).
 
Without a valid transitional arrangement or temporary permit, SoftOx cannot
place its disinfectant products based on this active substance on the market
until the Norwegian Environment Agency has approved SoftOx's new application.
SoftOx is now undertaking a thorough review of the letter from the Norwegian
Environment Agency and is considering submitting the case to the Ministry of
Climate and Environment.

In addition to the application for disinfection based on active chlorine
released from hypochlorous acid, there is an ongoing appeal process in the
Ministry of Climate and Environment regarding the approval of SoftOx
disinfection based on active chlorine released from sodium hypochlorite. This
application was rejected by KemI in Sweden, and an appeal is pending in the
Ministry of Climate and Environment as to whether there should be a deadline in
Norway for SoftOx to suspend sales by  October 3, 2021 with the possibility of
continued use for a period of six months thereafter

- We strongly disagree with the Norwegian Environment Agency's perception of the
regulations. We recently won the contract announced by HINAS (Helseforetakenes
Innkjøpsservice AS) for hand disinfection products, which shows that our product
is best in class. However, we believe in a good and fair treatment from the
Ministry of Climate and Environment, to continue to deliver products to our
customers. The conclusion is that the regulatory situation is still unclear,
says CEO Geir Almås of SoftOx Solutions.
 

For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

About SoftOx Solutions AS
SoftOx Solutions AS (Softx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com